Arcam Reports 125% Revenue Growth for 3rd Quarter, Shares up Nearly 27%

HeyGears Black Friday

Share this Article

ar4While the majority of stocks related to additive manufacturing are down from their highs earlier in the year, this is mainly due to the over-exuberance by investors late last year and into the start of 2014. Most of the major companies within the sector are doing quite well, with year-over-year growth on both their top and bottom lines.

One example of such, is Swedish-based company Arcam, who reported their third quarter financial results this morning. After a 4.5% drop in share price yesterday within the US markets, Arcam’s stock is up nearly 27% today on the Stockholm Stock Exchange, after a blowout report from the company.

Analysts had been expecting, on average, a reported operating profit for the quarter of around $431,000, while the company surprised to the upside, reporting a $600,000 profit. Additionally, analysts were looking for revenues to come in at around $9.8 million, while Arcam blew away these estimates, reporting $12.7 million in revenue for the third quarter.

Compared to quarter three of last year, the company has shown year-over-year revenue growth of 125%, while obtaining new clients, and growing their overall sales channels.ar3

Arcam, which specializes in the production of machines capable of printing objects in a variety of metal alloys, has over 50 patents to its name. Using Electron Beam Manufacturing (EBM), among other technologies, Arcam offers a variety of products and services within the additive manufacturing industry.

Highlights from this past quarter include the acquisition of contract manufacturer DiSanto Technology Inc. and the delivering of 9 EBM systems to clients, the majority within the aerospace and medical implant industries.

According to the company’s release today, “A strong order book and a positive business situation lay a solid foundation for a strong closing of 2014 and continued growth in 2015.”

After seeing a drop in share price of nearly 40% for the year, today’s news has allowed shares to rebound significantly, regaining much of those loses. Are you a shareholder of Arcam (NASDAQ:AMAVF) (STO:ARCM)? Discuss their latest report in the Arcam Q3 earnings forum thread on 3DPB.com.

ar2



Share this Article


Recent News

Post-Processing at Formnext 2025: Unpacking, Depowdering, Resin Removal, & More

Clecell Turns Stem Cells into 3D Printed Human Skin in the Lab



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

2.5D Mouse Muscle Tissue Made on Vomit Comet

In space, manufacturing has always been an area with much speculation but little actual progress. The idea is simple: zero or reduced gravity environments may be a better place to...

Tiny Bioprinter Could One Day Repair Vocal Cords During Surgery

A team of engineers and surgeons at McGill University in Montreal, Canada, has created the world’s smallest 3D bioprinter, and it could change how doctors repair damaged vocal cords. At...

When Bioprinting Enters the Room: Wyss Institute’s Chris Chen Joins the National Academy of Medicine

Christopher Chen, one of the architects behind Harvard’s 3D Organ Engineering Initiative, has been elected to the National Academy of Medicine (NAM), a rare honor that points to just how...